MARSHALL WACE, LLP - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$835,627
-64.8%
74,810
+49.1%
0.00%
-60.0%
Q2 2022$2,371,000
+227.9%
50,160
+418.7%
0.01%
+400.0%
Q4 2021$723,000
+72.6%
9,670
-2.8%
0.00%
-50.0%
Q4 2020$419,000
-73.8%
9,952
-71.5%
0.00%
-80.0%
Q3 2020$1,599,000
-75.8%
34,934
-73.5%
0.01%
-78.3%
Q2 2020$6,619,000
-48.9%
131,824
-47.7%
0.05%
-64.3%
Q1 2020$12,959,000
+15.9%
251,961
+39.2%
0.13%
+67.5%
Q4 2019$11,186,000
+8.0%
181,055
+5.0%
0.08%
-4.9%
Q3 2019$10,356,000
-20.2%
172,373
+12.1%
0.08%
-24.3%
Q2 2019$12,977,000
-53.0%
153,786
-46.8%
0.11%
-17.7%
Q1 2019$27,598,000
+156.5%
288,906
+90.2%
0.13%
+18.2%
Q4 2018$10,759,000
+59.9%
151,891
+92.9%
0.11%
+279.3%
Q3 2018$6,730,000
+475.2%
78,744
+202.7%
0.03%
+93.3%
Q2 2015$1,170,000
-69.0%
26,016
-78.9%
0.02%
-69.4%
Q1 2015$3,780,000
-61.8%
123,457
-36.6%
0.05%
-62.6%
Q4 2014$9,902,000
-20.9%
194,728
-38.5%
0.13%
-27.6%
Q3 2014$12,521,000
+8973.2%
316,426
+9742.2%
0.18%
+8950.0%
Q2 2014$138,0003,2150.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders